MAI-001 is under clinical development by Nanjing Minova Pharmaceutical Technology and currently in Phase I for Depression.
Rad AI Secures $60M for Generative AI Solutions for Radiology
What You Should Know: – Rad AI, one of the fastest-growing healthcare AI companies and the first to develop a large language model in healthcare, today